Release Date: 23/09/16 17:31 Summary: Clarification Regarding Media Commentary-BRB.AX Price Sensitive: No Download Document 44.85KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%